Latest Pharma Insights and Discussions
Exciting updates from the pharma world!
By Pharma Solutions India · 28 April 2025
At a glance
| Location | Global |
|---|---|
| Category | pharma |
| Published | 28 April 2025 |
Anaphylaxis is a type of hypersensitivity reaction.
Key points
- Terbinafine is an allylamine.
- Aspirin irreversibly inhibits COX.
- Anaphylaxis is a type I hypersensitivity reaction.
In a recent discussion, several key points in pharmacology were highlighted. Terbinafine, an allylamine, is noted for its antifungal properties. Aspirin, a well known drug, irreversibly inhibits COX, making it a potent anti inflammatory agent. Anaphylaxis, a severe allergic reaction, is classified as a type I hypersensitivity reaction. Additionally, MAO B inhibitors like selegiline and azole antifungals were discussed, showcasing the breadth of topics covered.
Anaphylaxis is a severe and rapid systemic allergic reaction that can be life threatening if not treated promptly.
For more details, follow @Pharmasolutionindia
This is a summary prepared by the Pharma Solutions India editorial team. Verify dates, fees and eligibility with the issuing authority before acting. Editorial policy · Disclaimer.